CFH accelerates the alternative C3 convertase through competitive binding with C3b and its inadequate recognition of cells can cause conditions such as atypical hemolytic uremic syndrome (aHUS), age-related macular degeneration (ARMD), and membrano-proliferative glomerulonephritis type II. This evidence concerns the gene C3 and age-related macular degeneration.